| answer text |
<p>The Department is doing everything appropriate to prepare for leaving the European
Union. We want to reassure patients that our plans should ensure the uninterrupted
supply of medicines and medical products once we have left the EU.</p><p> </p><p>The
department, as part of our EU exit preparations, is implementing a multi-layered approach
to mitigate potential disruption to supply, which consists of stockpiling where possible,
securing freight capacity, changing or clarifying regulatory requirements, procuring
additional warehousing, working closely with industry to improve trader readiness
and putting in place the National Supply Disruption Response to manage potential shortages.
Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans"
target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>For
any products that require air freight, such as some medical radioisotopes, the Department
is continuing to work with all suppliers to ensure this is in place ahead of 31 October.
The Department can confirm that all relevant suppliers now have plans in place or
are already airfreighting into the United Kingdom.</p><p> </p><p>The Department is
also undertaking joint operational testing, with key suppliers and other Government
Departments (Border Delivery Group, HM Revenue and Customs, Border Force) at East
Midlands airport to ensure the uninterrupted flow of goods. This testing includes
medical radioisotopes.</p><p> </p><p>The Department is in active communication with
the British Nuclear Medicine Society as well as with the Royal College of Radiologists
and the UK Radiopharmacy Group.</p><p> </p><p> </p><p> </p>
|
|
